ACHE and dementia: Based on these findings, the most promising hybrids 3a and 3c were investigated in the mouse scopolamine-induced dementia model to further evaluate their multimodal Aβ42-reducing properties, as well as excellent antioxidant and acetylcholinesterase inhibitory activities at the in vivo level.